The American Journal of Medicine
Volume 119, Issue 6, Supplement 1 , Pages S20-S28 , June 2006

Resistance in Gram-Negative Bacteria: Enterobacteriaceae

  • David L. Paterson, MD, PhD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to David L. Paterson, Suite 3A, Falk Medical Building, 3601 5th Avenue, Pittsburgh, Pennsylvania 15213

References 

  1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 . Am J Infect Control . 2004;32:470–485
  2. Paterson DL , Ko WC , Von Gottberg A , et al.   International prospective study of Klebsiella pneumoniae bacteremia (implications of extended-spectrum beta-lactamase production in nosocomial Infections) . Ann Intern Med . 2004;140:26–32
  3. Rupp ME , Fey PD . Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (considerations for diagnosis, prevention, and drug treatment) . Drugs . 2003;63:353–365
  4. Shah AA , Hasan F , Ahmed S , Hameed A . Extended-spectrum beta-lactamases (ESBLs) (characterization, epidemiology, and detection) . Crit Rev Microbiol . 2004;30:25–32
  5. Kollef MH , Sherman G , Ward S , Fraser VJ . Inadequate antimicrobial treatment of infections (a risk factor for hospital mortality among critically ill patients) . Chest . 1999;115:462–474
  6. Du B , Long Y , Liu H , et al.   Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection (risk factors and clinical outcome) . Intensive Care Med . 2002;28:1718–1723
  7. Paterson DL , Ko WC , Von Gottberg A , et al.   Antibiotic therapy for Klebsiella pneumoniae bacteremia (implications of production of extended-spectrum beta-lactamases) . Clin Infect Dis . 2004;39:31–37
  8. Bradford PA . Extended-spectrum beta-lactamases in the 21st century (characterization, epidemiology, and detection of this important resistance threat) . Clin Microbiol Rev . 2001;14:933–951 table of contents
  9. Walther-Rasmussen J , Hoiby N . Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases . Can J Microbiol . 2004;50:137–165
  10. Jacoby GA , Munoz-Price LS . The new beta-lactamases . N Engl J Med . 2005;352:380–391
  11. Walsh TR , Toleman MA , Poirel L , Nordmann P . Metallo-beta-lactamases (the quiet before the storm?) . Clin Microbiol Rev . 2005;18:306–325
  12. Thomson KS , Moland ES . Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae . Antimicrob Agents Chemother . 2001;45:3548–3554
  13. Jett BD , Ritchie DJ , Reichley R , Bailey TC , Sahm DF . In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins . Antimicrob Agents Chemother . 1995;39:1187–1190
  14. Paterson DL , Ko WC , Von Gottberg A , et al.   Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases (implications for the clinical microbiology laboratory) . J Clin Microbiol . 2001;39:2206–2212
  15. Wong-Beringer A , Hindler J , Loeloff M , et al.   Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime . Clin Infect Dis . 2002;34:135–146
  16. Data on file. Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement . Wayne, PA: Clinical and Laboratory Standards Institute; 2005;
  17. Zanetti G , Bally F , Greub G , et al.   Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients (a multicenter, evaluator-blind, prospective, randomized study) . Antimicrob Agents Chemother . 2003;47:3442–3447
  18. Alvarez M , Tran JH , Chow N , Jacoby GA . Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States . Antimicrob Agents Chemother . 2004;48:533–537
  19. Tracz DM , Boyd DA , Bryden L , et al.   Increase in AmpC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR . J Antimicrob Chemother . 2005;55:768–772
  20. Martinez-Martinez L , Hernandez-Alles S , Alberti S , Tomas JM , Benedi VJ , Jacoby GA . In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins . Antimicrob Agents Chemother . 1996;40:342–348
  21. Lautenbach E , Strom BL , Bilker WB , Patel JB , Edelstein PH , Fishman NO . Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae . Clin Infect Dis . 2001;33:1288–1294
  22. DiPersio JR , Deshpande LM , Biedenbach DJ , Toleman MA , Walsh TR , Jones RN . Evolution and dissemination of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae (epidemiology and molecular report from the SENTRY Antimicrobial Surveillance Program (1997–2003)) . Diagn Microbiol Infect Dis . 2005;51:1–7
  23. Hyle EP , Lipworth AD , Zaoutis TE , et al.   Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species . Clin Infect Dis . 2005;40:1317–1324
  24. Pitout JD , Nordmann P , Laupland KB , Poirel L . Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community . J Antimicrob Chemother . 2005;56:52–59
  25. Pitout JD , Hanson ND , Church DL , Laupland KB . Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases (importance of community isolates with blaCTX-M genes) . Clin Infect Dis . 2004;38:1736–1741
  26. Moland ES , Black JA , Hossain A , Hanson ND , Thomson KS , Pottumarthy S . Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from 5 US States . Antimicrob Agents Chemother . 2003;47:2382–2383
  27. Paterson DL , Hujer KM , Hujer AM , et al.   Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from 7 countries (dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamases) . Antimicrob Agents Chemother . 2003;47:3554–3560
  28. Colodner R , Rock W , Chazan B , et al.   Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients . Eur J Clin Microbiol Infect Dis . 2004;23:163–167
  29. Munday CJ , Whitehead GM , Todd NJ , Campbell M , Hawkey PM . Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK . J Antimicrob Chemother . 2004;54:628–633
  30. Rodriguez-Bano J , Navarro MD , Romero L , et al.   Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients . J Clin Microbiol . 2004;42:1089–1094
  31. Woodford N , Ward ME , Kaufmann ME , et al.   Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK . J Antimicrob Chemother . 2004;54:735–743
  32. Kruger T , Szabo D , Keddy KH , et al.   Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme, TEM-131, in South Africa . Antimicrob Agents Chemother . 2004;48:4263–4270
  33. Ishii Y , Kimura S , Alba J , et al.   Extended-spectrum beta-lactamase-producing Shiga toxin gene (Stx1)-positive Escherichia coli O26:H11 (a new concern) . J Clin Microbiol . 2005;43:1072–1075
  34. Kim S , Kim J , Kang Y , Park Y , Lee B . Occurrence of extended-spectrum beta-lactamases in members of the genus Shigella in the Republic of Korea . J Clin Microbiol . 2004;42:5264–5269
  35. Petroni A , Corso A , Melano R , et al.   Plasmidic extended-spectrum beta-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina . Antimicrob Agents Chemother . 2002;46:1462–1468
  36. Radice M , Gonzealez C , Power P , Vidal MC , Gutkind G . Third-generation cephalosporin resistance in Shigella sonnei, Argentina . Emerg Infect Dis . 2001;7:442–443
  37. Vignoli R , Varela G , Mota MI , et al.   Enteropathogenic Escherichia coli strains carrying genes encoding the PER-2 and TEM-116 extended-spectrum beta-lactamases isolated from children with diarrhea in Uruguay . J Clin Microbiol . 2005;43:2940–2943
  38. Li WC , Huang FY , Liu CP , et al.   Ceftriaxone resistance of nontyphoidal Salmonella enterica isolates in Northern Taiwan attributable to production of CTX-M-14 and CMY-2 β-lactamases . J Clin Microbiol . 2005;43:3237–3243
  39. Carattoli A , Tosini F , Giles WP , et al.   Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998 . Antimicrob Agents Chemother . 2002;46:1269–1272
  40. Dunne EF , Fey PD , Kludt P , et al.   Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase . JAMA . 2000;284:3151–3156
  41. Fey PD , Safranek TJ , Rupp ME , et al.   Ceftriaxone-resistant salmonella infection acquired by a child from cattle . N Engl J Med . 2000;342:1242–1249
  42. Bouza E , Cercenado E . Klebsiella and Enterobacter (antibiotic resistance and treatment implications) . Semin Respir Infect . 2002;17:215–230
  43. Chow JW , Fine MJ , Shlaes DM , et al.   Enterobacter bacteremia (clinical features and emergence of antibiotic resistance during therapy) . Ann Intern Med . 1991;115:585–590
  44. Levison ME , Mailapur YV , Pradhan SK , et al.   Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum beta-lactamase, in Enterobacter cloacae in Philadelphia Teaching Hospitals . Clin Infect Dis . 2002;35:1551–1554
  45. Sanders CC , Ehrhardt AF , Moland ES , Thomson KS , Zimmer B , Roe DE . BetalasEN (microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae) . J Clin Microbiol . 2002;40:123–127
  46. D’Agata E , Venkataraman L , DeGirolami P , Weigel L , Samore M , Tenover F . The molecular and clinical epidemiology of Enterobacteriaceae producing extended-spectrum beta-lactamase in a tertiary care hospital . J Infect . 1998;36:279–285
  47. Tzelepi E , Giakkoupi P , Sofianou D , Loukova V , Kemeroglou A , Tsakris A . Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes . J Clin Microbiol . 2000;38:542–546
  48. Park YJ , Park SY , Oh EJ , et al.   Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria . Diagn Microbiol Infect Dis . 2005;51:265–269
  49. Jiang X , Ni Y , Jiang Y , et al.   Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China . J Clin Microbiol . 2005;43:826–831
  50. Pai H , Hong JY , Byeon JH , Kim YK , Lee HJ . High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns . Antimicrob Agents Chemother . 2004;48:3159–3161
  51. Szabo D , Bonomo RA , Silveira F , et al.   SHV-type extended-spectrum beta-lactamase production is associated with reduced cefepime susceptibility in Enterobacter cloacae . J Clin Microbiol . 2005;43:5058–5064
  52. Carson C , Naber KG . Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections . Drugs . 2004;64:1359–1373
  53. Hooper DC . Clinical applications of quinolones . Biochim Biophys Acta . 1998;1400:45–61
  54. Xiong Z , Zhu D , Wang F , Zhang Y , Okamoto R , Inoue M . Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China . Diagn Microbiol Infect Dis . 2002;44:195–200
  55. Paterson DL , Mulazimoglu L , Casellas JM , et al.   Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia . Clin Infect Dis . 2000;30:473–478
  56. Hooper DC . Mechanisms of fluoroquinolone resistance . Drug Resist Updat . 1999;2:38–55
  57. Martinez-Martinez L , Pascual A , Jacoby GA . Quinolone resistance from a transferable plasmid . Lancet . 1998;351:797–799
  58. Wang M , Tran JH , Jacoby GA , Zhang Y , Wang F , Hooper DC . Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China . Antimicrob Agents Chemother . 2003;47:2242–2248
  59. Mammeri H , Van De Loo M , Poirel L , Martinez-Martinez L , Nordmann P . Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe . Antimicrob Agents Chemother . 2005;49:71–76
  60. Rodriguez-Martinez JM , Pascual A , Garcia I , Martinez-Martinez L . Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase . J Antimicrob Chemother . 2003;52:703–706
  61. Wang M , Sahm DF , Jacoby GA , Hooper DC . Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States . Antimicrob Agents Chemother . 2004;48:1295–1299
  62. Tran JH , Jacoby GA . Mechanism of plasmid-mediated quinolone resistance . Proc Natl Acad Sci U S A . 2002;99:5638–5642
  63. Bornet C , Davin-Regli A , Bosi C , Pages JM , Bollet C . Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability . J Clin Microbiol . 2000;38:1048–1052
  64. de Champs C , Henquell C , Guelon D , Sirot D , Gazuy N , Sirot J . Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem . J Clin Microbiol . 1993;31:123–127
  65. Chow JW , Shlaes DM . Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes . J Antimicrob Chemother . 1991;28:499–504
  66. Poirel L , Heritier C , Tolun V , Nordmann P . Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae . Antimicrob Agents Chemother . 2004;48:15–22
  67. Martinez-Martinez L , Pascual A , Hernandez-Alles S , et al.   Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae . Antimicrob Agents Chemother . 1999;43:1669–1673
  68. Bradford PA , Urban C , Mariano N , Projan SJ , Rahal JJ , Bush K . Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the loss of an outer membrane protein . Antimicrob Agents Chemother . 1997;41:563–569
  69. Lincopan N , McCulloch JA , Reinert C , Cassettari VC , Gales AC , Mamizuka EM . First isolation of metallo-beta-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil . J Clin Microbiol . 2005;43:516–519
  70. Giakkoupi P , Xanthaki A , Kanelopoulou M , et al.   VIM-1 Metallo-beta-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals . J Clin Microbiol . 2003;41:3893–3896
  71. Yan JJ , Ko WC , Tsai SH , Wu HM , Wu JJ . Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan . J Clin Microbiol . 2001;39:4433–4439
  72. Koh TH , Sng LH , Babini GS , Woodford N , Livermore DM , Hall LM . Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 beta-lactamase and lacking an outer membrane protein . Antimicrob Agents Chemother . 2001;45:1939–1940
  73. Galani I , Souli M , Chryssouli Z , Orlandou K , Giamarellou H . Characterization of a new integron containing bla(VIM-1) and aac(6′)-IIc in an Enterobacter cloacae clinical isolate from Greece . J Antimicrob Chemother . 2005;55:634–638
  74. Giakkoupi P , Tzouvelekis LS , Daikos GL , et al.   Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates . J Clin Microbiol . 2005;43:494–496
  75. Yigit H , Queenan AM , Anderson GJ , et al.   Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae . Antimicrob Agents Chemother . 2001;45:1151–1161
  76. Smith Moland E , Hanson ND , Herrera VL , et al.   Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates . J Antimicrob Chemother . 2003;51:711–714
  77. Bradford PA , Bratu S , Urban C , et al.   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City . Clin Infect Dis . 2004;39:55–60
  78. Woodford N , Tierno PM , Young K , et al.   Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center . Antimicrob Agents Chemother . 2004;48:4793–4799
  79. Bratu S , Landman D , Haag R , et al.   Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City (a new threat to our antibiotic armamentarium) . Arch Intern Med . 2005;165:1430–1435
  80. Bratu S , Mooty M , Nichani S , et al.   Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York (epidemiology and recommendations for detection) . Antimicrob Agents Chemother . 2005;49:3018–3020
  81. Bratu S , Landman D , Alam M , Tolentino E , Quale J . Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York . Antimicrob Agents Chemother . 2005;49:776–778
  82. Bratu S , Tolaney P , Karumudi U , et al.   Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY (molecular epidemiology and in vitro activity of polymyxin B and other agents) . J Antimicrob Chemother . 2005;56:128–132
  83. Miriagou V , Tzouvelekis LS , Rossiter S , Tzelepi E , Angulo FJ , Whichard JM . Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2 . Antimicrob Agents Chemother . 2003;47:1297–1300

PII: S0002-9343(06)00344-5

doi: 10.1016/j.amjmed.2006.03.013

The American Journal of Medicine
Volume 119, Issue 6, Supplement 1 , Pages S20-S28 , June 2006

Article Tools